Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study

June 6, 2013

Conclusions: This is the first study to examine characteristics associated with treatment outcome in patients dependent exclusively on prescription opioids. Characteristics associated with successful outcome after 12 weeks of buprenorphine/naloxone treatment include some that have previously been found to predict heroin-dependent patients’ response to methadone treatment and some specific to prescription opioid-dependent patients receiving buprenorphine/naloxone. […]

Read the full article →

OxyContin Manages Pain, yet Can Prove Addictive

June 1, 2013

OxyContin is a strong synthetic opioid that works in the body much like morphine to control people’s pain. Although the drug has proven extremely helpful for pain management, it can bring additional problems to people taking it. OxyContin is highly addictive. Called oxycodone in its generic form, OxyContin is considered a controlled substance. Physicians who […]

Read the full article →

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [Amneal Pharmaceuticals, LLC]

May 29, 2013

Updated Date: May 21, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology

May 22, 2013

Conclusions: This research using 2 medications will demonstrate whether BUP, administered in the presence of XR-NTX, reduces cocaine use in adults with cocaine dependence and opioid use disorders and will demonstrate if XR-NTX prevents development of physiologic dependence on BUP. (Source: Contemporary Clinical Trials) MedWorm Sponsor Message: Have a look at The Addiction Daily, the […]

Read the full article →

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [AvKARE, Inc.]

May 22, 2013

Updated Date: Apr 16, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Jennifer Serrentino, M.D. Recently Launches a Blog Post Discussing the…

May 22, 2013

Well known local psychiatrist, Jennifer Serrentino, M.D., recently discusses the Suboxone controversy on her blog.(PRWeb April 19, 2013)Read the full story at http://www.prweb.com/releases/Local-Port-Jefferson/Psychiatrist-Jennifer-Ser/prweb10636625.htm (Source: PRWeb: Medical Pharmaceuticals)

Read the full article →

Novel Opioid Dependence Pill Gets Patients' Thumbs-UpNovel Opioid Dependence Pill Gets Patients' Thumbs-Up

May 22, 2013

Compared with buprenorphine-naloxone sublingual film to treat opioid dependence, a sublingual menthol-flavored tablet has a preferred taste and comparable dissolve time. Medscape Medical News (Source: Medscape Today Headlines)

Read the full article →

Acute Pain Control Challenges with Buprenorphine/Naloxone Therapy in a Patient with Compartment Syndrome Secondary to McArdle's Disease: A Case Report and Review

May 22, 2013

We report the first case of non‐iatrogentic exertional rhabdomyolysis leading to acute compartment syndrome in a patient with McArdle’s disease. We describe considerations of concurrent buprenorphine/naloxone therapy during episodes of severe acute pain. DesignCase report. Case PresentationA 50‐year‐old male with a history of McArdle’s disease, taking buprenorphine/naloxone for chronic pain and opioid dependence, presented to […]

Read the full article →

Not Otherwise Specified: Anxiety & the Work of Dr. Robert Hudak

May 22, 2013

Southwest Pennsylvania National Alliance on Mental Illness (NAMI) held its annual conference at the beginning of April, and one of their afternoon breakout workshop presenters was Dr. Robert Hudak, assistant professor of psychiatry at Western Psychiatric Institute & Clinic, University of Pittsburgh. “Pathways to Hope: Shaping a Positive Future in Uncertain Times” was the conference […]

Read the full article →

Oxycontin and the Strongest Addiction

May 15, 2013
Thumbnail image for Oxycontin and the Strongest Addiction

Oxycontin is one of the substances that creates the strongest of addictions. A mere three to four weeks and many can become dependent. This is a powerful drug, and in the past decade it has been popularized among young drug users. Opium in all its forms Denise was only 16 years old when she started […]

Read the full article →

← Previous Entries

Next Entries →